Please provide your email address to receive an email when new articles are posted on . In the PIVOTAL trial, patients undergoing hemodialysis with ferritin concentration less than 400 µg/L and a ...

The researchers found that patients received a median monthly iron dose of 264 and 145mg in the high- and low-dose groups, respectively. HealthDay News — For patients undergoing maintenance ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — The PIVOTAL Trial has shown in patients undergoing hemodialysis, that the use of higher-dose IV iron ...

Until now, no other treatment has been shown to reduce heart attack risk in patients on dialysis. High-dose intravenous (IV) iron reduces the risk for acute myocardial infarction in patients receiving ...

Patients on hemodialysis who received high-dose had similar rates of infection and rates of hospitalization for infection compared with those treated with low-dose IV iron, a secondary analysis of the ...

A new paper in Cardiovascular Research, published by Oxford University Press, indicates that iron treatments may reduce heart attacks in patients experiencing kidney failure undergoing dialysis.

PRINCETON, N.J., July 16, 2021 /PRNewswire/ — Sandoz, a global leader in generic and biosimilar medicines, today announced the immediate US availability of generic Ferumoxytol, an intravenous medicine ...

A single dose of intravenous (IV) iron dextran is the most cost-effective treatment for women with heavy menstrual bleeding and iron deficiency anemia (IDA), according to new research published in ...

Anemia during pregnancy is a common occurrence and often due to iron deficiency. It is a global public health problem, affecting an estimated 37 percent of pregnant individuals, according to the World ...

(HealthDay)—For patients undergoing maintenance hemodialysis, a high-dose intravenous iron regimen administered proactively is noninferior to a low-dose intravenous iron regimen administered ...